Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DAVILA

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Transplantation and Cellular Therapy|March 30, 2021
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationDoris K Hansen, Jongphil Kim, Zachary Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial ResultsJoseph Pidala, Kelly Walton, Hany Elmariah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict MortalityShernan G Holtan, Constanza Savid-Frontera, Kelly Walton, et al.
Cardio-Oncology (London, England)|April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studyDae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.
Blood Advances|February 26, 2021
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantationNelli Bejanyan, Joseph A Pidala, Xuefeng Wang, et al.
Science Translational Medicine|March 22, 2013
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemiaRenier J Brentjens, Marco L Davila, Isabelle Riviere, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene CiloleucelRawan Faramand, Michael Jain, Verena Staedtke, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Transplantation and Cellular Therapy|March 30, 2021
ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationDoris K Hansen, Jongphil Kim, Zachary Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial ResultsJoseph Pidala, Kelly Walton, Hany Elmariah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict MortalityShernan G Holtan, Constanza Savid-Frontera, Kelly Walton, et al.
Cardio-Oncology (London, England)|April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studyDae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.
Blood Advances|February 26, 2021
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantationNelli Bejanyan, Joseph A Pidala, Xuefeng Wang, et al.
Science Translational Medicine|March 22, 2013
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemiaRenier J Brentjens, Marco L Davila, Isabelle Riviere, et al.
Gastrointestinal Endoscopy|April 26, 2015
Natural language processing as an alternative to manual reporting of colonoscopy quality metricsGottumukkala S Raju, Phillip J Lum, Rebecca S Slack, et al.
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood|January 29, 2021
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphomaMichael D Jain, Hua Zhao, Xuefeng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene CiloleucelRawan Faramand, Michael Jain, Verena Staedtke, et al.
Pageof 10